$0.298700
00.00%
Last update: 9:25 AM
15 minutes delayed
Comments
Loading...
Renalytix
RNLXNASDAQ
Renalytix (NASDAQ:RNLX) Stock, Analyst Ratings, Price Targets, Forecasts
Renalytix PLC has a consensus price target of $4.5 based on the ratings of 3 analysts. The high is $7 issued by Stifel on July 1, 2022. The low is $3 issued by HC Wainwright & Co. on July 12, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on July 12, 2024, June 30, 2023, and June 12, 2023, respectively. With an average price target of $4.33 between HC Wainwright & Co., there's an implied 1350.73% upside for Renalytix PLC from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
BTIG
Stifel
1calculated from analyst ratings
Analyst Ratings for Renalytix
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/12/2024 | Buy Now | 904.35% | HC Wainwright & Co. | Yi Chen | $3 → $3 | Reiterates | Buy → Buy | Get Alert |
| 06/30/2023 | Buy Now | 1573.92% | HC Wainwright & Co. | Yi Chen | → $5 | Reiterates | Buy → Buy | Get Alert |
| 06/12/2023 | Buy Now | 1573.92% | HC Wainwright & Co. | Yi Chen | → $5 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | Buy Now | 1573.92% | HC Wainwright & Co. | Yi Chen | → $5 | Reiterates | → Buy | Get Alert |
| 04/03/2023 | Buy Now | 1071.74% | BTIG | Mark Massaro | $4 → $3.5 | Maintains | Buy | Get Alert |
| 04/03/2023 | Buy Now | 1573.92% | HC Wainwright & Co. | Yi Chen | $8 → $5 | Maintains | Buy | Get Alert |
| 12/02/2022 | Buy Now | 2578.27% | HC Wainwright & Co. | Yi Chen | $10 → $8 | Maintains | Buy | Get Alert |
| 11/01/2022 | Buy Now | 3247.84% | HC Wainwright & Co. | Yi Chen | $15 → $10 | Maintains | Buy | Get Alert |
| 07/01/2022 | Buy Now | 1573.92% | BTIG | Mark Massaro | $15 → $5 | Maintains | Buy | Get Alert |
| 07/01/2022 | Buy Now | 2243.49% | Stifel | Daniel Arias | $17 → $7 | Maintains | Buy | Get Alert |
| 07/01/2022 | Buy Now | 4921.76% | HC Wainwright & Co. | Yi Chen | $30 → $15 | Maintains | Buy | Get Alert |
| 01/18/2022 | Buy Now | 9943.52% | HC Wainwright & Co. | Yi Chen | → $30 | Initiates | → Buy | Get Alert |
| 01/04/2022 | Buy Now | 7934.82% | BTIG | Mark Massaro | → $24 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Renalytix (RNLX) stock?
The latest price target for Renalytix (NASDAQ:RNLX) was reported by HC Wainwright & Co. on July 12, 2024. The analyst firm set a price target for $3.00 expecting RNLX to rise to within 12 months (a possible 904.35% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Renalytix (RNLX)?
The latest analyst rating for Renalytix (NASDAQ:RNLX) was provided by HC Wainwright & Co., and Renalytix reiterated their buy rating.
When was the last upgrade for Renalytix (RNLX)?
There is no last upgrade for Renalytix
When was the last downgrade for Renalytix (RNLX)?
There is no last downgrade for Renalytix.
When is the next analyst rating going to be posted or updated for Renalytix (RNLX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Renalytix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Renalytix was filed on July 12, 2024 so you should expect the next rating to be made available sometime around July 12, 2025.
Is the Analyst Rating Renalytix (RNLX) correct?
While ratings are subjective and will change, the latest Renalytix (RNLX) rating was a reiterated with a price target of $3.00 to $3.00. The current price Renalytix (RNLX) is trading at is $0.30, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.